Eudaimonia Partners, LLC Abb Vie Inc. Transaction History

Eudaimonia Partners, LLC

$416 Million
Q1 2024

A detailed history of Eudaimonia Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Eudaimonia Partners, LLC holds 3,609 shares of ABBV stock, worth $615,948. This represents 0.16% of its overall portfolio holdings.

Number of Shares

3,609

Previous 3,816 5.42%

Holding current value

$615,948

Previous $591,000 11.17%

% of portfolio

0.16%

Previous 0.16%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$159.82 - $182.1 $33,082 - $37,694	-207 Reduced 5.42%	3,609 $657,000
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $525,081 - $591,365	3,816 New	3,816 $591,000
Q2 2023 Jul 19, 2023	BUY	$132.51 - $164.9 $54,329 - $67,609	410 Added 7.35%	5,991 $807,000
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $792,607 - $912,805	-5,481 Reduced 49.55%	5,581 $889,000
Q4 2022 Jan 24, 2023	SELL	$138.31 - $165.87 $421,845 - $505,903	-3,050 Reduced 21.61%	11,062 $0
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $1.6 Million - $1.84 Million	-11,950 Reduced 45.85%	14,112 $1.89 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $5,091 - $6,473	-37 Reduced 0.14%	26,062 $3.99 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $576,752 - $715,587	4,370 Added 20.11%	26,099 $4.23 Million
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $156,301 - $177,425	-1,469 Reduced 6.33%	21,729 $2.34 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $325,204 - $362,296	3,091 Added 15.37%	23,198 $2.61 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $192,528 - $211,950	-1,882 Reduced 8.56%	20,107 $2.18 Million
Q4 2020 Feb 18, 2021	SELL	$80.49 - $108.67 $21,732 - $29,340	-270 Reduced 1.21%	21,989 $2.36 Million
Q3 2020 Nov 23, 2020	BUY	$85.91 - $100.83 $1.84 Million - $2.16 Million	21,373 Added 2412.3%	22,259 $1.95 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $2.01 Million - $2.36 Million	-23,445 Reduced 96.36%	886 $23,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $89,731 - $120,074	1,223 Added 5.29%	24,331 $2.39 Million
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $317,211 - $480,931	4,918 Added 27.04%	23,108 $1.76 Million
Q4 2019 May 05, 2020	BUY	$72.13 - $90.25 $1.31 Million - $1.64 Million	18,190 New	18,190 $1.61 Million

Others Institutions Holding ABBV

# of Institutions

3,869

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.

Account

Eudaimonia Partners, LLC Abb Vie Inc. Transaction History